CL2014003247A1 - Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal. - Google Patents

Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.

Info

Publication number
CL2014003247A1
CL2014003247A1 CL2014003247A CL2014003247A CL2014003247A1 CL 2014003247 A1 CL2014003247 A1 CL 2014003247A1 CL 2014003247 A CL2014003247 A CL 2014003247A CL 2014003247 A CL2014003247 A CL 2014003247A CL 2014003247 A1 CL2014003247 A1 CL 2014003247A1
Authority
CL
Chile
Prior art keywords
immunogenize
mammals
mammal
escherichia coli
cell wall
Prior art date
Application number
CL2014003247A
Other languages
Spanish (es)
Inventor
Acevedo Lisette Nicole Lapierre
Iturriaga Leonardo Enrique Sáenz
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Priority to CL2014003247A priority Critical patent/CL2014003247A1/en
Publication of CL2014003247A1 publication Critical patent/CL2014003247A1/en
Priority to BR112017011292-2A priority patent/BR112017011292B1/en
Priority to PCT/CL2015/050046 priority patent/WO2016082054A1/en
Priority to MX2017006892A priority patent/MX2017006892A/en
Priority to CONC2017/0005389A priority patent/CO2017005389A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2014003247A 2014-11-28 2014-11-28 Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal. CL2014003247A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CL2014003247A CL2014003247A1 (en) 2014-11-28 2014-11-28 Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.
BR112017011292-2A BR112017011292B1 (en) 2014-11-28 2015-11-25 SUBUNIT, POLIVALENT, HIGHLY IMMUNOGENIC VACCINE AGAINST MASTITIS IN MAMMALS, PROCESS FOR PREPARING SAID VACCINE AND USES THEREOF
PCT/CL2015/050046 WO2016082054A1 (en) 2014-11-28 2015-11-25 Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals
MX2017006892A MX2017006892A (en) 2014-11-28 2015-11-25 Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals.
CONC2017/0005389A CO2017005389A2 (en) 2014-11-28 2017-05-26 Subunit, polyvalent highly immunogenic vaccine against mastitis in mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014003247A CL2014003247A1 (en) 2014-11-28 2014-11-28 Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.

Publications (1)

Publication Number Publication Date
CL2014003247A1 true CL2014003247A1 (en) 2015-07-10

Family

ID=56073267

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003247A CL2014003247A1 (en) 2014-11-28 2014-11-28 Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.

Country Status (5)

Country Link
BR (1) BR112017011292B1 (en)
CL (1) CL2014003247A1 (en)
CO (1) CO2017005389A2 (en)
MX (1) MX2017006892A (en)
WO (1) WO2016082054A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024072985A1 (en) * 2022-09-28 2024-04-04 University Of Tennessee Research Foundation Polyvalent vaccines for staphylococcal & streptococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011018858A1 (en) * 2009-08-14 2011-02-17 エヌエーアイ株式会社 Novel mastitis vaccine

Also Published As

Publication number Publication date
BR112017011292B1 (en) 2024-01-16
WO2016082054A9 (en) 2016-06-23
CO2017005389A2 (en) 2017-07-19
WO2016082054A1 (en) 2016-06-02
BR112017011292A2 (en) 2017-12-26
MX2017006892A (en) 2018-01-23

Similar Documents

Publication Publication Date Title
IL285972B (en) Preparations digested by bees, their use to create honey and the honey produced by their use
HUE054103T2 (en) Isoquinolin-3-ylcarboxamides, their preparation and use
HUE053084T2 (en) Vaccine preparation for Streptococcus suis infection
IL264454A (en) New preparations, uses and methods for their preparation
BR112016021626A2 (en) 5-substituted indazol-3-carboxamides and their preparation and use
HUE051862T2 (en) Stable anti-IFNAR1 preparation
EP3351540A4 (en) CYCLOHEXANE DERIVATIVE OR STEREOISOMER OR SALT THEREOF, PREPARATION AND USE THEREOF
IL244697A0 (en) Preparations and formulations for preserving and increasing muscle mass, strength, and performance and methods for their production and use
EP3253368A4 (en) Cannabinoid and sugar alcohol complex, methods to make and use
BR112016011830A2 (en) synergistic bacterial compositions and methods for their production and use.
DK3137168T3 (en) SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE
EP3119424A4 (en) Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
GB2532302B (en) Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms.
HUE046033T2 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
EP3273989C0 (en) STREPTOCOCCAL VACCINE
LT3169307T (en) AQUEOUS COMPOSITION INCLUDING PARACETAMOL AND IBUPROPHENE
PL3232780T3 (en) Aqueous electrolyte-containing adjuvant compositions, active ingredient-containing compositions and the use thereof
EP3528839C0 (en) EXPEC GLYCOCONJUGATE VACCINE FORMULATIONS
DK3355933T3 (en) ADENINE CONJUGATE COMPOUNDS AND THEIR USE AS VACCINE ADJUVANCES
PL3794204T3 (en) ASYMMETRIC, SAFE, VACUUM-INSULATED GLASS UNIT
HUE063831T2 (en) Procedure for the production, use and delivery of activated stem cells
IL265869A (en) Vaccine constructs and uses thereof against staphylococcus infections
DK3344289T3 (en) PESTIVIRUS VACCINES AGAINST BIRTH TREMOR
HRP20180773T1 (en) SILDENAFIL SOLUTIONS, PROCEDURES FOR THEIR PREPARATION AND USE
CL2014003247A1 (en) Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.